| Trial ID: | L0819 |
| Source ID: | NCT03184376
|
| Associated Drug: |
Prebiotic
|
| Title: |
Histological Improvement of Non-alcoholic Steatohepatitis With a Prebiotic: a Pilot Clinical Trial
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease;Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Dietary Supplement: Prebiotic oligofructose;Dietary Supplement: Placebo maltodextrin;Dietary Supplement: Prebiotic oligofructose;Dietary Supplement: Placebo maltodextrin;Dietary Supplement: Prebiotic oligofructose;Dietary Supplement: Placebo maltodextrin;
|
| Outcome Measures: |
Histological change;Histological change;Histological changeBody composition;Body weight;Glucose tolerance;Gut microbiota;Serum total cholesterol;Serum LDL cholesterol;Serum triglycerides;Serum HDL cholesterol;Serum IL-6;Serum TNF-alpha
|
| Sponsor/Collaborators: |
University of Calgary
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Not applicable
|
| Enrollment: |
14
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
| Start Date: |
08/06/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
16 December 2017
|
| Locations: |
--
|
| URL: |
https://clinicaltrials.gov/show/NCT03184376
|
